<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 308 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page307.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=308">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 308 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 308</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=308"><img src="../thumb/308.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>Anti-Microbials - 18.12                                                        2020-04 / 271
       rhabdomyolys., malaise, fatig., fev., hypersens.reacts.incl. anaphy-  cat., headache, hypoasthes., memory impairm., neuropath./periph.  odynophag., ac.pancreatit., pept.ulc., rect. haemorrh., fatig., chest/
       lax., trans.rise in ser.liv.enzym./ser.amylas  neuropathy, paraesthes., part.seiz., restless leg syndr., sleep phase   anorect./epigastr. discomf., chills, hypertens., feel.hot., irritabil., drug
       Warnings and special precautions: Poss. contin. of HIV compli-  rhythm disturb., somnol., syncope, trem., azotaem., dysur., noctur.,   tol., fac./periph.oed., fat tiss.incr., jitter., malaise, submandibul.mass.,
       cat.& opportunist infects., ther. not proven to prev.transmiss., ren./  proteinur., ren.fail., urin. incont., ED, genit.prurit.fem., gynaecomast.,   hepatobil.disords., immune. reconstit.syndr., drug hypersens., hypers-
       hepat. impairm., adv.cirrhot.liv.dis.due to chron.Hepatit.B infect.,   penis disord., bronchosp., cough, dysphon., dyspn. exertion., epistax.,   ens., cellulit., infects.incl. H.simplex, genit.herpes, incr./ decr. weight,
       discont.use if pancreat./lact.acidos./ hepatotoxic. suspect., risk fact.  rhinorh., sinus congest., skin & subcutan. tiss.disords.incl.alopec.,   decr.appet., diab.mellit., central obesity, dyslipidaem., hyperlactaem.,
       for liv.dis., avoid future NNRTI’s use aft.recovery from lact.acidos.,   eryth., hyperhidros., lipodystroph., lipohypertroph, angioneurot. oed.,   hyperlipidaem., hypertriglyceridaem., cachexia, hyperphagia, incr.
       concom. co-trimoxaz.in pts.with ren.impairm.  erythema.multiform.& fac swell., vasc.disords.incl.flush., hypertens.,   appetite, lipomatos., polydips., arthralg., myalg., extrem.pain, back/
       Drug interactions: Trimethoprim incr.plasma conc., intracell.phos-  hypertens. crisis., hypotens., haemorrh.stroke. See prod.lit.for treatm.  neck/flank pain, osteopen., musc.spasms, tendonit., rhabdomyolys.,
       phorylat.of zalcitabine inhibit.  emergent clinic.lab.abnormal  musc.skelet.pain, myosit., musc. atrophy, amyotrophy, osteoporos.,
       HEVAZ 600, (Activo) Hetero [P/S]  Special precautions: Treatm.hist. & resist.test. should guide   CNS effs., periph. neurolog.sympts., psych.disords. incl. suicid. ideat.&
                                     use, not recomm.for use in combin. with only N(t)RTIs in pts.who
       Efavirenz.                    have exper.virolog. fail.on NNRTI- & N(t)RTI-contain.regim., discont.  behav., ren./urin.disords., nephrolithias., ren.fail., erect.dysfunct., gy-
       Indications: In combinat.with other antiretrovir. agents for HIV-1   on signs/sympts.of sev.skin reacts./hypersens. reacts., eval.for   naecomast., menopaus.sympts., epistax., dysphon., nas.congest., skin
       infect.adults, adolesc.& childr. weigh. 40 kg and above.  physic.signs of fat redistribut./any inflammat.sympts.instit.treatm.  disords., Stev.John. syndr., breast. Ca.
       (S4) TABS, 43/20.2.8/0363, 600 mg  when necess., cont.lact  Warnings and special precautions: Poss. inflamm. respon.to
       715591-001: 30, R243,30       Drug interactions: Decr.plasma conc.of meds. metabolis.by CY-  indol./resid.opportunist. infects. necessitat.furth.eval.& treatm., con-
       Dosage: Admin.in combinat.with a protease inhibit./ nucleoside   P3A4, incr.plasma conc.of meds. metabolis.by CYP2C9/CYP2C19,   com. strong induc.of uridine diphosphate glucuronosyltransferase
       analog. Admin.on empty stomach. Avoid admin.with a fatty meal   co-admin.with other NNRTIs/unboosted PIs (atazanavir, ritonavir,   (UGT)1A1 (eg.rifampin), elderly, cancers observ.of which types and
       as absorpt. incr              nelfinavir, fosamprenavir, indinavir, saquinavir) not recomm., AUC   rates expect.in high.immunodefic.populat.& most pts had other risk
       Adults & Adolesc. &gt; 40kg: Recomm.dos: 600 mg once dly.   & C min signific.reduc.with tipranavir boosted with ritonavir, con-  fact.theref.unknown if relat.to use, pts. at incr.risk of myopathy/
       Contraindications: Concom.astemizole /cisapride/ midazolam/  com.fosamprenavir/ amprenavir boosted with ritonavir req.dos.   rhabdomyolysis, AST & ALT abnormalit.high.in chron.act.hepatit.B
       triazolam/ergot derivat.as ser./life threat.adverse effs.poss., pregn.   adjustm., incr.anticoag.activ.with warfarin, decr. plasma conc.with   and/ or C pts., formulat.not bioequiv - do not substit. chew.tab.for
       (teratogen. in anim.), breast feed not recomm., childr. und.3 yrs./  carbamazepine/phenobarbital /phenytoin/rifampicin/rifampin/rifap-  400 mg tab., lact.intol.
       weight &lt; 13 kg, concom.St John’s Wort.  entin/ St.John’s Wort/system.dexamethasone, incr. plasma conc.  Drug interactions: Plasma conc.reduc.by potent UGT1A1 induc.
       Side effects: Weight gain/loss, CNS effs., abnorm. co-ordinat.,   with posaconazole/itraconazole/ ketoconazole, decr.plasma conc.  (rifampin), plasma lev.incr.by potent UGT1A1 inhibit.(atazanavir).,
       convuls., paraesthes., periph. neuropathy, trem., psych.disords., ag-  of concomit. itraconazole/ketoconazole/amiodarone/bepridil/ dis-  plasma lev.poss.incr. by meds.known to incr.gastric pH.
       grav.depress., impot., libido changes, speech disords., abnorm. vis.,   opyramide/flecainide/system.lidocaine/ mexiletine/ propafenone/  KALETRA, Abbvie [P/S] &
       tinnit., taste pervers., palpitat., flush., tachycard., asthma, sinusit.,   quinidine/lovastatin/ rosuvastatin/simvastatin, incr.plasma conc.  Lopinavir 80 mg, ritonavir 20 mg/ml
       dyspn., URTI, GI disturbs., malabsorpt., hepatit., hepat.fail., skin re-  of concom. diazepam, fluvastatin/rosuvastatin, activit.of concom.
       acts. incl.rash/erythema multiforme & Stev. John. syndr., alopec.,   clarithromycin against Mycobacter.avium complex alt., plasma conc.  Indications: HIV infect.in combinat.with other antiretroviral agents.
                                                                  (S4) ORAL SOL, 35/20.2.8/0255.
       incr.sweat., acne, nail disords., skin discolourat., arthralg./myalg.,   of concom.cyclosporine/sirolimus/tacrolimus/atorvastatin/ sildena-
       myopathy, fatig., alcoh.intol., allerg.reacts., asthen., hot flush., flu-  fil/vardenafil/tadalafil poss.affect.  700924-019: 5x60 ml, R361,60
                                                                  Dosage: Admin.with food.
       like sympts., malaise, pain, anorex., incr.appet., redistrib./accumu-
       lat.of body fat, syncope, incr.hepat.enzymes., rais.ser. cholester.&   INVERTRON, Novagen [P/S]  Adults: Ther.naïve pts: Recomm.dos: 400/100 mg (i.e. 5 ml) 2xdly.
       triglycerid.conc., incr.tot.cholester.  Abacavir sulph.    OR 800/200 mg (i.e.10 ml) once dly. Ther.exper.pts: 400/100 mg (i.e.5
       Warnings and special precautions: Must not be used as mon-  Indications: Antiretroviral combinat.ther. for HIV treatm.in infect.  ml) 2xdly. Once dly.dos.not stud.in ther.exper.pts.theref.not recomm.
       other./add.on as sole agent to fail. regim., ser.nerv.syst.& psych.  adults & childr.  Concom.efavirenz/nevirapine/amprenavir/ nelfinavir: Consid.
       sympts.report., use barrier contracept.in combinat.with other meth-  (S4) TABS, 41/20.2.8/0248  incr.to 533/133 mg(6,5 ml) 2xdly.in treatm.exper.pts.where reduc.lopi-
       ods, consid. alternat.to clarithromycin, monit.liv. enzymes with con-  715493-001: 300 mg, 60, R1 068,31  navir susceptib.suspect. Do not admin.as once-dly. regim.in combin.
       com.ritonavir, teratogenic. report., pregn.test in women of childbear.  (S4) ORAL SOL., 41/20.2.8/0386  with efavirenz/nevirapine/ amprenavir/nelfinavir.
       potent. bef. init.ther., pass.into breast milk, ref.to prod.lit. when pre-  715494-001: 20 mg/ml, 240 ml, R400.79   Childr: 6 mnths-12 yrs: Calc.approx.mg dos.for each indiv.pt.less
       scrib.other meds., consid.simultan. discont. of all antiretrovir.meds.if   Dosage: For use by physic.exper.in HIV managem.  than/equal to 12 yrs.
       combinat.regim. is interrupt.because of suspect.intol.& restart med-  Adults & adolesc.over 12 yrs: Recomm.dos: One 300 mg tab.  7 to less than 15 kg: 12/3 mg/kg 2xdly. 15-40 kg: 10/2,5 mg/kg
       ic.at same time upon resolut.of intol.sympts., intermitt.monother./se-  or 15 ml oral sol.2xdly.  2xdly. Great.than 40 kg: Up to max. 400/100 mg 2xdly. Once-dly
       quent.reintroduct.not advis., discont. in sev.rash & consid.prophylax.  Childr.3 mnths-12 yrs: Recomm.dos: 8 mg/kg 2xdly up to   dos.not evaluat.in paed.pts.
       with appropr. anthistam./corticoster.for mild to mod. rash to improv.  max.600 mg dly.  Concom.efavirenz/nevirapine/amprenavir /nelfinavir: Consid.
       tol.& resolv.rash, be alert to psychos. -like reacts.& sev.ac.depress.  Contraindications: Hepat.impairm., pregn.& lactat., childr.  incr.as follows: 7 to less than 15 kg: 13/3,25 mg/kg 2x dly. 15-45
       reports, ment. illn./subst.abuse hist., suicid.ideat./ attempts. report.,   und.3 mnths.  kg: 11/2,75 mg/kg 2xdly. Great.than 45 kg: Up to max.533/133
       liv.impairm., monit.liv.enzymes partic. in known/suspect. hepatit.B/C   Side effects: Lact.acidos.& sev.hepatomegaly with steatos.in most.  mg 2xdly.in treatm.exper.childr.6 mnths-12 yrs.where reduc.lopi-
       infect.hist./ concom. hepatotox.meds., weigh.benef.vs risk in pts   women, hypersens. react.   somet. fatal with foll.sympt: lymphopen.,   navir susceptib. suspect.
       with persist.ser.transamin.elev.&gt; 5xULN, cholestrol. monit., use not   paraesthes., headache, dyspn., sore throat, cough, GI disords., hepat.  See lit.for dos.guidelines accord.to body surf.area.
       assess.in paed. pts.bel. 3 yrs./weigh.&lt;13 kg.  fail., elev.LFT, rash, ren.fail., hypersens. sympts.worsen.with cont.  Contraindications: Safety in pregn.& lactat.not est., concom.
       Interactions: Addit.CNS effs.with alcoh./ psychoact. meds, plasma   ther., fatig., fev., malaise, oed., lymphadenopathy, hypotens., con-  drugs depend.on CYP3A for clear. where elev.plasma conc.are
       conc.of other compds. that are substrates of CYP3A4 poss.decr.,   junctivit., anaphylax., elev.bld.gluc./triglycerid., diarrh., skin reacts.  assoc.with ser./life-threaten. events: blonanserin/midazolam /
       AUC & C trough of indinavir decr., incr.freq.of S/E with ritonavir, decr.  incl.Stev.Johns.syndr./ erythema multiforme/tox.epiderm.necrolys.,   triazolam/ ergotamine/dihydroergotamine/ ergonovine/ methy-
       saquinavir/clarithromycin. AUC & C max, rifampicin decr.AUC & C max,   lethargy, pancreatit.  lergonovine/pimozide/cisapride /astemizole & terfenadine/
       potent.interact with OC’s, methadone plasma lev.decr.result.in opi-  Special precautions: Hypersens.reacts.charact. by multi-organ/  tipranavir/salmeterol/ sildenafil (in PAH treatm.only), concom.
       ate withdr.signs in HIV infect.IV drug users, expect. reduc.plasma   body syst.involvem. have proven fatal, sympt.usuall.appear with.1   st  rifampin/ St John’s Wort, concom.lovastatin/simvastatin & vori-
       conc.with St John’s Wort.     6 wks.of ther., discont.ther.if hypersens.react.devel.& not to be   conazole not recomm.
       INTELENCE, Janssen [P/S]      re-challeng., opportunist.infects. & other HIV complicat.may still   Side effects: Hyperglycaem., diabet.ketoacidos., pancreatit., di-
                                                                  arrh., bact/viral infect., bronchit., sinusit., gastroenterit., otit.media,
                                     devel., advis.pt.that antiretrovir. ther.not been prov.to prev. trans-
       Etravirine                    miss. through sex.cont./bld.contam.& appropr.precaut.to contin.,   furunculos., flu syndr., sialadenit., benign skin neoplasm, cyst, bld.
       Indications: Treatm.of HIV-1 infect.in antiretrovir. treatm-exper.  known liv.dis.risk fact., susp.treatm.if clinic./laborat.find.suggest.  dyscras., allerg.reacts., male hypogonad., Cushings syndr., hypo-
       adult pts.with NNRTI resist.in combinat. with other antiretrovir.meds.  of lact.acidos./ hepatotoxic.devel., heredit.fruct.intol., incr.in ma-  thyroid., avitaminos., dehydrat., incr. appetite, lact.acidos., obesity,
       (S4) TABS, 48/20.2.8/1301, 43/20.2.8/0780  lign. & non-malign.tumours in laborat.anim., potent.clinic.benef.
       720247-001: 25 mg, 120, R177,09  outweighs carcinogen.risk.  anorex., diabet. mellit., weight gain/loss, psych.disords., CNS effs.,
                                                                  encephalopathy, fac.paralys., hyperton., neuropathy, paraesthes., pe-
       713800-002: 100 mg, 120, R580,39  Drug interactions: Metabol.alter.by concom. ethanol, C max reduc./
       Dosage: Always give in combinat.with other antiretrovir.meds. Tak.  one hr.delay in t max with methadone, poss.interact. with retinoid   riph.neurit., taste loss/ pervers., migraine, dyskines., cerebr.infarct,
       aft.food to achiev.optim. expos.  cmpds.but not stud.      convuls., extrapyramid.syndr., abnorm.vis., eye disords., tinnit., ver-
       Adults: 200 mg 2x/day. Childr.&lt;12 yrs.& adolesc: Not recommend.  tigo, palpitat., arter.fibrillat., MI, hypertens., thrombophlebit,. vari-
       Contraindications: Decr.plasma conc.with carbamazep./pheno-  ISENTRESS, MSD [P/S]  cose vein, vasculit., vasc.disords., postur.hypotens., dyspn., rhinit.,
       barbit./phenyt/rifampic./ rifapentin./St.John’s Wort, incr.plasma   Raltegravir  asthma, lung oed., incr.cough, other GI disturbs. incl. haemorrhag.
       conc.with posaconazol/itraconaz/ketoconaz., decr.plasma conc.of   Indications: In combinat.with other anti-retrovir. agents for HIV-1   colit., enlarg.abdom., abdom. pain, dysphag., mouth ulcerat., sto-
       concom..itraconaz/ketoconaz., safety & effic.not demonstr.in pregn./  infect.in pts.2yrs of age & older.  matit., periodonit., hepatobil.disords., arthralg., arthros., myalg.,
       lactat./childr.& adolesc.     (S4) TABS, 42/20.2.8/0687    back pain, bone necros., joint disord., myasthen., abnorm.ejaculat.,
       Side effects: Rash, diarrh., naus., hypertriglyceridaem., hypercho-  715825-001: 400 mg, 60, R1 091,59  breast enlargem., gynaecomast., impot., skin rash, lipodystrophy,
       lesterolaem., Stev.-Johns. syndr & tox.epiderm.necrolys., hypers-  S4) CHEW.TABS, 46/20.2.8/0863, 0864  alopec., dry skin, eczema, exfoliat.dermatit., maculopapul. rash, nail
       ens. reacts., immun.reconstitut.syndr., organ dysfunct. incl. hepat.  720591-001: 25 mg, 60, R281,66  disord., prurit., seborrh., skin discolourat., skin ulc., face oed., acne,
       fail., pyrex., malaise., fatig., musc./ joint aches, blisters, oral les.,   720590-001: 100 mg, 60, R563,32  sweat., skin striae, asthen., chest pain, chills, fev., malaise, pain, pe-
       conjunctivit., hepatit., eosinophil., bld.dyscras., card.disords. incl.  Dosage: Adults: 400 mg twice dly.with/-out food in combinat.regim.  riph. oed., drug interact., oed., hypertrophy, Stev.John.syndr., eryth.
       atrial fibrillat.& tachycard., vertigo, eye disords., GI disords., colit.,   with other antiretrovir.agents. Childr.& adolesc: &gt; 12 yrs: 1 x 400   multif., bradyarrhythm., kidn.calcul., urine abnormalit., nephrit., re-
       haematemes., pancreatit., oral paraesthes., stomatit., asthen., chest   mg tab.twice dly., 6-11 yrs: 1 x 400 mg tab.twice dly.(if weight&gt; 25   distribut./accumulat.of body fat, incr. total cholester./triglycer.conc.,
       pain., chills, hot flush., irrit., periph.oed., pain, sluggishn., cytolyt.hep-  kg) OR chew.tabs.based on weight to max. 300 mg 2xdly.  immune reconstit. syndr.
       atit., hepat.steatos., hepatomeg., immune.syst.disords., H.Simplex/   Chew.tab recom.dos.bas.on approx.6 mg/kg/dose 2 xdly. Chew   Special precautions: New onset/exacerbat.of exist. diabet.mel-
       Zoster infects., H.Zoster multi-dermatos., BP/ alanin. aminotransfer./  tab 100 mg can be div.into equal halves. Paediatrics: 7 to &lt; 10   lit., mark.elev.triglyceride incr. pancreatit. risk, pancreatit.hist., safety
       aspartate.aminotransfer./ bilirub. conjug./bld.alkalin.phosphatas./  kg: 50 mg 2x/day, 10 to &lt; 14 kg: 75 mg 2x/day, 14 to &lt; 20 kg: 100   & effic. beyond 96 wks.not est., admin.didanosine 1 hr. bef. /2 hrs.
       bld. amylase/ bld.bilirub./bld.cholest./bld.creatin. phosphokinas./  mg 2x/day, 20 to &lt; 28 kg: 150 mg 2x/day, 28 to &lt; 40 kg: 200 mg   aft., consid.alternat.to intranas.admin. fluticasone partic.for long-
       bld.creatinin./bld.gluc./bld.lactat. dehydrogen./bld.thyr.stimulat.  2x/day, At least 40 kg: 300 mg 2x/day. Max dly.dos. of chew.tab.:   term use, concom. antiarrhythm./digox.& warfar.conc.poss.affect.
       horm./bld. triglycerid./ bld.uric acid/eosinop.count/hepat. enzyme/  300 mg 2x/day.  theref. monit.recom., ketoconazole & itraconazole dos.&gt; 200 mg/
       lipase/lipids/LDL/transaminase./urin. bilirub./weight incr., creatin.  Contraindications: No well controll.studies in pregn., not recomm.  day not recomm., use low.poss.dos. of concom.atorvastat., adopt.
       ren.clear./haemoglob. decr., abnorm.ECG/ ECG changes, lympho-  in breastfeed., safety & effectiven.in childr.&lt;2 yrs.not est.  addit./alternat.to hormon. contracept., advers.effs.of concom. silde-
       cyte. morpholog./PT vibrat.test abnorm., prot.urin./red bld.cell nu-  Side effects: Diarrh., naus., abdom.distens./pain, flatul.,headache,   nafil /tadalafil & varadenafil poss.incr., hepat. impairm., underly.
       cleat.morphol., anorex., decr./incr. appetit., diab.mellit., dislipidaem.,   nasopharyngit., URTI, bronchit., vomit., pyrex., lipodystrophy, bld.  hepatit.B/C, protease inhibit. cross-resist., incr.bleed.in haemophilia
       gout, hypercreatinaem., hyperglycaem., hyperlipidaem., arthralg.,   dyscras., skin papill., MI, palpitat., ventric.extrasystol., sinus brady-  type A & B report., PR interv.prolong., monit.triglycer./ cholester. prior
       arthrit., gouty arthrit., musc.spasms., myalg., osteoporos., extremit.  card., tinnit., vertigo, vis.disturbs., abdom. pain /discomf., gastrit.,   to & dur.treatm., inflam.respons.to asymptomat./ resid. opportunist.
       pain., ageus., amnes., burn.sensat., convuls., dizzin., dysgeus., formi-  glossit., GORD, dry mouth, asthen.,eros.duodenit. eructat., gingivit.,   infects.(eg mycobacterium avium) req.further eval./treatm., oppor-</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page307.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page303.html">303</a>&nbsp;&nbsp;&nbsp;<a href="page304.html">304</a>&nbsp;&nbsp;&nbsp;<a href="page305.html">305</a>&nbsp;&nbsp;&nbsp;<a href="page306.html">306</a>&nbsp;&nbsp;&nbsp;<a href="page307.html">307</a>&nbsp;&nbsp;&nbsp;<a href="page308.html">308</a>&nbsp;&nbsp;&nbsp;<a href="page309.html">309</a>&nbsp;&nbsp;&nbsp;<a href="page310.html">310</a>&nbsp;&nbsp;&nbsp;<a href="page311.html">311</a>&nbsp;&nbsp;&nbsp;<a href="page312.html">312</a>&nbsp;&nbsp;&nbsp;<a href="page313.html">313</a>
             </td>
             <td width="35%"><a href="page309.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page309.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
